查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1865393

全球后生元外用市场：预测（至2032年）－依产品类型、活性成分、应用、最终使用者、通路和地区进行分析

Postbiotic Topicals Market Forecasts to 2032 - Global Analysis By Product Type, Active Ingredient, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球益生元外用产品市场价值将达到 1.382 亿美元，到 2032 年将达到 2.677 亿美元。

预计在预测期内，后生元外用产品将以9.9%的复合年增长率成长。后生元外用产品是一种以非活性微生物产品（例如酵素、胜肽和代谢物）配製而成的护肤配方，旨在维护皮肤健康。后生元不含活菌，因此更稳定，更适合外用。这些生物活性化合物有助于增强皮肤屏障、减少发炎并促进微生物群平衡。后生元外用产品广泛应用于皮肤科和化妆品领域，可为敏感肌、痤疮肌或老龄化肌提供针对性功效，并避免了活性菌丛带来的风险。

皮肤问题增多，例如痤疮、湿疹和皮肤敏感。

痤疮、湿疹和敏感肌肤等皮肤问题的日益增多，促使消费者对注重微生物群的护肤越来越感兴趣。这催生了对温和配方、支持皮肤屏障功能的需求。后生元具有抗炎和舒缓功效，且稳定性优于活性菌，因此非常适合敏感肌肤。临床证据和消费者对洁净标示产品日益增长的需求进一步强化了这一趋势。随着消费者寻求针对性缓解，后生元外用产品在治疗和美容领域都越来越受欢迎。

高昂的製造成本和复杂的製造工艺

与传统活性成分不同，后生元需要精确的发酵、纯化和稳定步骤才能保持其功效。这些过程通常需要专用设备和熟练人员，从而增加了营运成本。此外，监管合规和品质保证通讯协定也会增加成本负担。对于新兴品牌和配方商而言，这些障碍会限制其规模化生产和价格竞争力，儘管消费者兴趣日益增长，但市场渗透速度仍然缓慢。

开发创新后生元配方，以解决特定的皮肤问题

透过将生物活性代谢物与互补成分结合，品牌可以开发出兼具美容和治疗功能的多功能产品。封装技术和递送系统的创新正在提高产品的稳定性和皮肤吸收率，进一步扩大其潜在应用范围。此外，消费者对有益于微生物群的护肤产品的需求日益增长，推动了研发投入，为产品差异化和高端定位铺平了道路，尤其是在临床级和健康导向型产品线方面。

其他护肤活性成分的激烈竞争

后生元外用市场面临来自成熟护肤活性成分（如类视色素、胜肽、神经酰胺和烟碱酰胺）的激烈竞争。这些成分拥有多年消费者信赖、广泛的临床检验以及涵盖各种价格分布的广泛供应等优势。因此，后生元不仅要在功效上竞争，还要在成本、认知度和品牌忠诚度方面与之抗衡。此外，围绕微生物组健康的营销宣传仍在不断发展，这可能会阻碍消费者的理解。

新冠疫情的影响：

新冠疫情初期扰乱了益生元外用产品的供应链和生产运营，导致产品上市延迟和原料采购困难。然而，这场危机也加速了消费者对皮肤健康和免疫力的关注，推动了对支持微生物群配方产品的需求。萤幕使用时间的增加和口罩的广泛佩戴导致皮肤刺激普遍存在，促使消费者转向修復皮肤屏障和抗炎产品。电子商务和线上护肤咨询的兴起进一步推动了市场的復苏。

预计在预测期内，乳霜和乳液细分市场将占据最大的市场份额。

预计在预测期内，乳霜和乳液类产品将占据最大的市场份额。这是因为乳霜和乳液因其易于涂抹、亲肤亲和性且适用于所有年龄层，仍然是后生元外用产品的首选剂型。这些剂型能够有效分散生物活性化合物，并被广泛应用于治疗和美容护理中。它们具有保湿、舒缓和强化皮肤屏障的功效，使其成为后生元成分的理想载体。此外，各大品牌正越来越多地将后生元添加到日常保湿霜和精华液中，进一步巩固了其市场主导地位。

预计在预测期内，抗衰老和屏障修復领域将呈现最高的复合年增长率。

预计在预测期内，抗衰老龄化和屏障修復领域将实现最高成长率，这主要得益于消费者对年轻健康肌肤日益增长的需求。后生元因其促进细胞更新、减少氧化压力和增强皮肤微生物群的作用而备受认可。这些益处与消费者对非侵入性、对微生物群友善的抗衰老龄化解决方案日益增长的需求相契合。此外，后生元温和地取代了刺激性强的活性成分，使其适用于成熟和敏感肌肤。临床研究和高级产品的推出也进一步推动了该领域的成长。

占比最大的地区：

预计北美将在预测期内占据最大的市场份额，这主要得益于其先进的护肤产业、较高的消费者意识和强大的分销网络。该地区拥有强大的研发能力，并率先应用了微生物组科学，同时消费者对洁净标示和功能性护肤的偏好也推动了市场成长。此外，美国和加拿大的主要品牌和皮肤科医生正在积极推广添加后生元的产品，进一步提升了市场渗透率。

复合年增长率最高的地区：

由于可支配收入增加、美容意识增强以及对皮肤健康解决方案的需求不断增长，预计亚太地区在预测期内将实现最高的复合年增长率。该地区充满活力的电子商务环境和网主导行销正在加速产品的普及。此外，当地製造商正在加大对后生元的研究和开发投入，以开发出更具成本效益且符合当地文化习惯的配方。这一发展势头使亚太地区成为市场成长的关键引擎。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球后生元外用市场（依产品类型划分）

  • 介绍
  • 乳霜和乳液
  • 美容精华/浓缩液
  • 凝胶和软膏
  • 口罩及贴片
  • 喷雾/雾
  • 其他产品类型

6. 全球后生元外用产品市场（依活性成分划分）

  • 介绍
  • 基于短链脂肪酸（SCFA）的后生元
  • 细菌裂解液和细胞分离上清液
  • 细胞外多醣体及其组成
  • 发酵衍生的代谢物
  • 混合配方和多效配方

7. 全球后生元外用产品市场（依应用领域划分）

  • 介绍
  • 敏感肌肤和易泛红肌肤
  • 用于治疗异位性皮肤炎和湿疹的辅助药物
  • 痤疮和皮脂调节
  • 抗衰老和屏障修復
  • 创伤治疗/术后护理
  • 色素沉着和肤色矫正

8. 全球后生元外用市场（依最终用户划分）

  • 介绍
  • 皮肤科诊所和处方药物治疗
  • 护肤品牌、非处方药零售商
  • 美容及个人护理
  • 电子商务/D2C品牌
  • 水疗、专业美容护理

9. 全球后生元外用产品市场（依分销通路划分）

  • 介绍
  • 药局/药局连锁店
  • 美容零售商、百货公司
  • 电子商务平台、品牌网站
  • 专业频道
  • 直销和订阅模式

第十章 全球后生元外用市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：公司简介

  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Kerry Group plc
  • dsm-firmenich
  • Associated British Foods plc
  • BASF SE
  • Novonesis
  • International Flavors & Fragrances Inc.
  • MCLS Europe BV
  • Lesaffre Group
  • Lallemand Inc.
  • Sami-Sabinsa Group Limited
  • CJ CheilJedang Corporation
  • Biotenova Sdn. Bhd.
  • Bioprox Healthcare
  • Church & Dwight Co., Inc.
Product Code: SMRC32196

According to Stratistics MRC, the Global Postbiotic Topicals Market is accounted for $138.2 million in 2025 and is expected to reach $267.7 million by 2032, growing at a CAGR of 9.9% during the forecast period. Postbiotic topicals are skincare formulations infused with non-living microbial byproducts such as enzymes, peptides, and metabolites that support skin health. Postbiotics do not contain live bacteria, making them more stable and suitable for topical use. These bioactive compounds help reinforce the skin barrier, reduce inflammation, and promote a balanced microbiome. Widely used in dermatology and cosmetic applications, postbiotic topicals offer targeted benefits for sensitive, acne-prone, or aging skin without the risks associated with live cultures.

Market Dynamics:

Driver:

Rising prevalence of skin conditions like acne, eczema, and sensitivity

Acne, eczema, and sensitivity conditions have heightened consumer awareness around microbiome-friendly skincare, prompting interest in non-irritating, barrier-supportive formulations. Postbiotics offer anti-inflammatory and soothing benefits without the instability of live cultures, making them ideal for sensitive skin. This trend is further reinforced by clinical endorsements and growing demand for clean-label products. As consumers seek targeted relief, postbiotic topicals are gaining traction across both therapeutic and cosmetic applications.

Restraint:

High production costs and complex manufacturing processes

Unlike conventional actives, postbiotics require precise fermentation, purification, and stabilization steps to retain efficacy. These processes often demand specialized equipment and skilled personnel, increasing operational overheads. Additionally, regulatory compliance and quality assurance protocols add to the cost burden. For emerging brands and formulators, these barriers can limit scalability and price competitiveness, thereby slowing broader market penetration despite rising consumer interest.

Opportunity:

Development of innovative postbiotic blends for targeted skin concerns

By combining bioactive metabolites with complementary ingredients, brands can create multifunctional products that address both aesthetic and therapeutic needs. Innovations in encapsulation and delivery systems are enhancing stability and skin absorption, further expanding application potential. Moreover, consumer demand for microbiome-supportive skincare is encouraging R&D investments. This opens avenues for differentiation and premium positioning, especially in clinical-grade and wellness-focused product lines.

Threat:

Intense competition from other skincare active ingredients

The postbiotic topicals market is challenged by intense competition from established skincare actives such as retinoids, peptides, ceramides, and niacinamide. These ingredients have long-standing consumer trust, extensive clinical validation, and widespread availability across price tiers. As a result, postbiotics must compete not only on efficacy but also on cost, familiarity, and brand loyalty. Furthermore, marketing claims around microbiome health are still evolving, which may hinder consumer understanding.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted supply chains and manufacturing operations for postbiotic topicals, delaying product launches and limiting ingredient availability. However, the crisis also accelerated consumer interest in skin health and immunity, driving demand for microbiome-supportive formulations. Increased screen time and mask usage led to widespread skin irritation, prompting a shift toward barrier-repair and anti-inflammatory products. E-commerce growth and digital skincare consultations further supported market recovery.

The creams & lotions segment is expected to be the largest during the forecast period

The creams & lotions segment is expected to account for the largest market share during the forecast period as creams and lotions remain the most preferred format for postbiotic topical delivery due to their ease of application, skin compatibility, and versatility across age groups. These formats allow for effective dispersion of bioactive compounds and are widely accepted in both therapeutic and cosmetic routines. Their ability to hydrate, soothe, and reinforce the skin barrier makes them ideal carriers for postbiotic ingredients. Moreover, brands are increasingly integrating postbiotics into daily-use moisturizers and serums, reinforcing their dominance in the market.

The anti-aging & barrier repair segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the anti-aging & barrier repair segment is predicted to witness the highest growth rate driven by rising consumer demand for skin longevity and resilience. Postbiotics are gaining recognition for their role in enhancing cellular renewal, reducing oxidative stress, and fortifying the skin's microbiome. These benefits align with the growing preference for non-invasive, microbiome-friendly anti-aging solutions. Additionally, postbiotics offer a gentler alternative to harsh actives, making them suitable for mature and sensitive skin. This segment's growth is further supported by clinical studies and premium product launches.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced skincare industry, high consumer awareness, and robust distribution networks. The region benefits from strong R&D capabilities and early adoption of microbiome science and growing preference for clean-label and functional skincare boosts this regions market. Moreover, leading brands and dermatologists in the U.S. and Canada are actively promoting postbiotic formulations, further driving market penetration.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rising disposable incomes, expanding beauty consciousness, and increasing demand for skin health solutions. The region's dynamic e-commerce landscape and influencer-driven marketing are accelerating product adoption. Additionally, local manufacturers are investing in postbiotic R&D, contributing to cost-effective and culturally tailored formulations. This momentum positions Asia Pacific as a key growth engine for the market.

Key players in the market

Some of the key players in Postbiotic Topicals Market include Cargill, Incorporated, Archer Daniels Midland Company, Kerry Group plc, dsm-firmenich, Associated British Foods plc, BASF SE, Novonesis, International Flavors & Fragrances Inc., MCLS Europe B.V., Lesaffre Group, Lallemand Inc., Sami-Sabinsa Group Limited, CJ CheilJedang Corporation, Biotenova Sdn. Bhd., Bioprox Healthcare, and Church & Dwight Co., Inc.

Key Developments:

In October 2025, Cargill has conducted human clinical trials highlighting their postbiotic raw material EpiCor, a dried fermentate from Saccharomyces cerevisiae. Results show anti-inflammatory properties and positive effects on skin inflammation when applied topically, reducing microvascular inflammatory responses and irritation in skin models.

In June 2025, dsm-firmenich Animal Nutrition & Health has announced the launch of GutServ(R) Biotics, an innovative postbiotic solution designed to support piglet health, resilience and performance.

In February 2025, ADM a global leader in innovative solutions from nature, announced today its agreement with Asahi Group Foods Corporation, a leading food company headquartered in Japan, to exclusively market and distribute Asahi Group's proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305.

Product Types Covered:

  • Creams & Lotions
  • Serums & Concentrates
  • Gels & Ointments
  • Masks & Patches
  • Sprays & Mists
  • Other Product Types

Active Ingredients Covered:

  • Short-chain fatty acid (SCFA)-based postbiotics
  • Bacterial lysates & cell-free supernatants
  • Exopolysaccharides & polysaccharide fractions
  • Fermentation-derived metabolites
  • Blends & Multi-active Formulations

Applications Covered:

  • Sensitive & Redness-prone Skin
  • Atopic Dermatitis & Eczema adjuncts
  • Acne & Sebum Regulation
  • Anti-Aging & Barrier Repair
  • Wound Healing / Post-procedural Care
  • Hyperpigmentation & Tone Correction

End Users Covered:

  • Dermatology Clinics & Prescribable Treatments
  • Dermatocosmetic Brands & OTC Retail
  • Beauty & Personal Care
  • E-commerce / D2C brands
  • Spas & Professional Aesthetics

Distribution Channels Covered:

  • Pharmacies & Drugstore Chains
  • Beauty Retailers & Department Stores
  • E-Commerce Marketplaces & Brand Websites
  • Professional Channels
  • Direct Sales & Subscription Models

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Postbiotic Topicals Market, By Product Type

  • 5.1 Introduction
  • 5.2 Creams & Lotions
  • 5.3 Serums & Concentrates
  • 5.4 Gels & Ointments
  • 5.5 Masks & Patches
  • 5.6 Sprays & Mists
  • 5.7 Other Product Types

6 Global Postbiotic Topicals Market, By Active Ingredient

  • 6.1 Introduction
  • 6.2 Short-chain fatty acid (SCFA)-based postbiotics
  • 6.3 Bacterial lysates & cell-free supernatants
  • 6.4 Exopolysaccharides & polysaccharide fractions
  • 6.5 Fermentation-derived metabolites
  • 6.6 Blends & Multi-active Formulations

7 Global Postbiotic Topicals Market, By Application

  • 7.1 Introduction
  • 7.2 Sensitive & Redness-prone Skin
  • 7.3 Atopic Dermatitis & Eczema adjuncts
  • 7.4 Acne & Sebum Regulation
  • 7.5 Anti-Aging & Barrier Repair
  • 7.6 Wound Healing / Post-procedural Care
  • 7.7 Hyperpigmentation & Tone Correction

8 Global Postbiotic Topicals Market, By End User

  • 8.1 Introduction
  • 8.2 Dermatology Clinics & Prescribable Treatments
  • 8.3 Dermatocosmetic Brands & OTC Retail
  • 8.4 Beauty & Personal Care
  • 8.5 E-commerce / D2C brands
  • 8.6 Spas & Professional Aesthetics

9 Global Postbiotic Topicals Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Pharmacies & Drugstore Chains
  • 9.3 Beauty Retailers & Department Stores
  • 9.4 E-Commerce Marketplaces & Brand Websites
  • 9.5 Professional Channels
  • 9.6 Direct Sales & Subscription Models

10 Global Postbiotic Topicals Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Cargill, Incorporated
  • 12.2 Archer Daniels Midland Company
  • 12.3 Kerry Group plc
  • 12.4 dsm-firmenich
  • 12.5 Associated British Foods plc
  • 12.6 BASF SE
  • 12.7 Novonesis
  • 12.8 International Flavors & Fragrances Inc.
  • 12.9 MCLS Europe B.V.
  • 12.10 Lesaffre Group
  • 12.11 Lallemand Inc.
  • 12.12 Sami-Sabinsa Group Limited
  • 12.13 CJ CheilJedang Corporation
  • 12.14 Biotenova Sdn. Bhd.
  • 12.15 Bioprox Healthcare
  • 12.16 Church & Dwight Co., Inc.

List of Tables

  • Table 1 Global Postbiotic Topicals Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Postbiotic Topicals Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Postbiotic Topicals Market Outlook, By Creams & Lotions (2024-2032) ($MN)
  • Table 4 Global Postbiotic Topicals Market Outlook, By Serums & Concentrates (2024-2032) ($MN)
  • Table 5 Global Postbiotic Topicals Market Outlook, By Gels & Ointments (2024-2032) ($MN)
  • Table 6 Global Postbiotic Topicals Market Outlook, By Masks & Patches (2024-2032) ($MN)
  • Table 7 Global Postbiotic Topicals Market Outlook, By Sprays & Mists (2024-2032) ($MN)
  • Table 8 Global Postbiotic Topicals Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Postbiotic Topicals Market Outlook, By Active Ingredient (2024-2032) ($MN)
  • Table 10 Global Postbiotic Topicals Market Outlook, By Short-chain Fatty Acid (SCFA)-based Postbiotics (2024-2032) ($MN)
  • Table 11 Global Postbiotic Topicals Market Outlook, By Bacterial Lysates & Cell-free Supernatants (2024-2032) ($MN)
  • Table 12 Global Postbiotic Topicals Market Outlook, By Exopolysaccharides & Polysaccharide Fractions (2024-2032) ($MN)
  • Table 13 Global Postbiotic Topicals Market Outlook, By Fermentation-derived Metabolites (2024-2032) ($MN)
  • Table 14 Global Postbiotic Topicals Market Outlook, By Blends & Multi-active Formulations (2024-2032) ($MN)
  • Table 15 Global Postbiotic Topicals Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Postbiotic Topicals Market Outlook, By Sensitive & Redness-prone Skin (2024-2032) ($MN)
  • Table 17 Global Postbiotic Topicals Market Outlook, By Atopic Dermatitis & Eczema Adjuncts (2024-2032) ($MN)
  • Table 18 Global Postbiotic Topicals Market Outlook, By Acne & Sebum Regulation (2024-2032) ($MN)
  • Table 19 Global Postbiotic Topicals Market Outlook, By Anti-Aging & Barrier Repair (2024-2032) ($MN)
  • Table 20 Global Postbiotic Topicals Market Outlook, By Wound Healing / Post-procedural Care (2024-2032) ($MN)
  • Table 21 Global Postbiotic Topicals Market Outlook, By Hyperpigmentation & Tone Correction (2024-2032) ($MN)
  • Table 22 Global Postbiotic Topicals Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Postbiotic Topicals Market Outlook, By Dermatology Clinics & Prescribable Treatments (2024-2032) ($MN)
  • Table 24 Global Postbiotic Topicals Market Outlook, By Dermatocosmetic Brands & OTC Retail (2024-2032) ($MN)
  • Table 25 Global Postbiotic Topicals Market Outlook, By Beauty & Personal Care (2024-2032) ($MN)
  • Table 26 Global Postbiotic Topicals Market Outlook, By E-commerce / D2C Brands (2024-2032) ($MN)
  • Table 27 Global Postbiotic Topicals Market Outlook, By Spas & Professional Aesthetics (2024-2032) ($MN)
  • Table 28 Global Postbiotic Topicals Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 29 Global Postbiotic Topicals Market Outlook, By Pharmacies & Drugstore Chains (2024-2032) ($MN)
  • Table 30 Global Postbiotic Topicals Market Outlook, By Beauty Retailers & Department Stores (2024-2032) ($MN)
  • Table 31 Global Postbiotic Topicals Market Outlook, By E-Commerce Marketplaces & Brand Websites (2024-2032) ($MN)
  • Table 32 Global Postbiotic Topicals Market Outlook, By Professional Channels (2024-2032) ($MN)
  • Table 33 Global Postbiotic Topicals Market Outlook, By Direct Sales & Subscription Models (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.